Upgrade to SI Premium - Free Trial

Doximity Announces Fiscal 2025 Third Quarter Financial Results

February 6, 2025 4:01 PM

Total revenues of $168.6 million, up 25% year-over-year

Net income growth of 57% and adjusted EBITDA growth of 39% year-over-year

SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 third quarter ended December 31, 2024.

“We’re proud to deliver another quarter of record engagement in Q3, with over 610,000 unique providers using our clinical workflow tools,” said Jeff Tangney, co-founder and CEO of Doximity. “Our AI tools grew the fastest last quarter, up 60% over the prior quarter, while our newsfeed surpassed more than one million unique providers.”

Fiscal 2025 Third Quarter Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended December 31, 2023.

Financial Outlook

Doximity is providing guidance for its fiscal fourth quarter ending March 31, 2025 as follows:

Doximity is updating guidance for its fiscal year ending March 31, 2025 as follows:

Conference Call Information

Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.

About Doximity

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

Forward-Looking Statements

Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024 and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

DOXIMITY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

December 31, 2024

March 31, 2024

Assets

Current assets:

Cash and cash equivalents

$

165,270

$

96,785

Marketable securities

679,670

666,115

Accounts receivable, net

137,504

101,332

Prepaid expenses and other current assets

30,259

48,709

Total current assets

1,012,703

912,941

Property and equipment, net

13,477

12,318

Deferred income tax assets

43,079

45,068

Operating lease right-of-use assets

9,332

12,332

Intangible assets, net

24,134

27,317

Goodwill

67,940

67,940

Other assets

1,492

1,458

Total assets

$

1,172,157

$

1,079,374

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$

1,636

$

2,253

Accrued expenses and other current liabilities

42,793

43,703

Deferred revenue, current

69,197

99,145

Operating lease liabilities, current

2,255

2,149

Total current liabilities

115,881

147,250

Deferred revenue, non-current

73

211

Operating lease liabilities, non-current

10,692

12,397

Contingent earn-out consideration liability, non-current

5,498

10,895

Other liabilities, non-current

8,893

7,224

Total liabilities

141,037

177,977

Stockholders' Equity

Preferred stock

Common stock

188

187

Additional paid-in capital

878,701

823,885

Accumulated other comprehensive income (loss)

1,015

(2,664

)

Retained earnings

151,216

79,989

Total stockholders’ equity

1,031,120

901,397

Total liabilities and stockholders’ equity

$

1,172,157

$

1,079,374

DOXIMITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

Three Months Ended
December 31,

Nine Months Ended
December 31,

2024

2023

2024

2023

Revenue

$

168,603

$

135,284

$

432,111

$

357,365

Cost of revenue(1)

14,181

12,190

41,407

38,102

Gross profit

154,422

123,094

390,704

319,263

Operating expenses(1):

Research and development

22,421

19,946

68,235

61,835

Sales and marketing

38,491

34,956

108,102

99,612

General and administrative

13,585

9,641

32,943

27,854

Restructuring and impairment charges

2,304

7,936

Total operating expenses

74,497

64,543

211,584

197,237

Income from operations

79,925

58,551

179,120

122,026

Other income, net

9,915

4,481

26,060

15,223

Income before income taxes

89,840

63,032

205,180

137,249

Provision for income taxes

14,644

15,076

44,453

30,285

Net income

$

75,196

$

47,956

$

160,727

$

106,964

Net income per share attributable to Class A and Class B common stockholders:

Basic

$

0.40

$

0.26

$

0.86

$

0.56

Diluted

$

0.37

$

0.24

$

0.80

$

0.52

Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:

Basic

187,161

186,309

186,344

191,302

Diluted

202,233

200,463

200,625

207,265

(1) Costs and expenses include stock-based compensation expense as follows (in thousands):

Three Months Ended
December 31,

Nine Months Ended
December 31,

2024

2023

2024

2023

Cost of revenue

$

2,818

$

2,466

$

8,373

$

7,205

Research and development

4,471

3,080

14,602

8,874

Sales and marketing

6,487

4,060

19,881

12,752

General and administrative

5,592

2,165

11,470

6,742

Restructuring

3,646

Total stock-based compensation expense

$

19,368

$

11,771

$

54,326

$

39,219

DOXIMITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

Three Months Ended
December 31,

Nine Months Ended
December 31,

2024

2023

2024

2023

Cash flows from operating activities

Net income

$

75,196

$

47,956

$

160,727

$

106,964

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

2,655

2,509

7,830

7,717

Deferred income taxes

1,992

2,196

Stock-based compensation, net of amounts capitalized

19,368

11,771

54,326

39,219

Non-cash lease expense

441

522

1,392

1,599

Accretion of discount on marketable securities, net

(3,368

)

(1,683

)

(8,736

)

(3,477

)

Amortization of deferred contract costs

1,785

1,548

6,544

6,278

Impairment of long-lived assets

2,304

Other

411

1,500

289

1,627

Changes in operating assets and liabilities:

Accounts receivable

(12,986

)

(1,135

)

(36,464

)

8,509

Prepaid expenses and other assets

1,303

6,523

21,251

(3,981

)

Deferred contract costs

(5,853

)

(4,477

)

(9,069

)

(6,925

)

Accounts payable, accrued expenses and other liabilities

9,418

10,429

3,872

2,366

Deferred revenue

(24,628

)

(24,823

)

(30,085

)

(38,576

)

Operating lease liabilities

(545

)

(586

)

(1,599

)

(1,168

)

Net cash provided by operating activities

65,189

50,054

174,778

120,152

Cash flows from investing activities

Purchases of property and equipment

(36

)

(147

)

Internal-use software development costs

(1,771

)

(1,288

)

(5,018

)

(4,020

)

Purchases of marketable securities

(164,025

)

(101,112

)

(531,833

)

(281,338

)

Maturities of marketable securities

99,308

105,418

517,221

318,186

Sales of marketable securities

7,564

37,150

14,805

74,675

Net cash provided by (used in) investing activities

(58,924

)

40,132

(4,825

)

107,356

Cash flows from financing activities

Proceeds from issuance of common stock upon exercise of stock options and common stock warrants

3,662

2,540

13,905

9,758

Proceeds from issuance of common stock in connection with the employee stock purchase plan

1,422

1,494

Taxes paid related to net share settlement of equity awards

(8,107

)

(1,248

)

(16,329

)

(5,332

)

Repurchase of common stock

(19,307

)

(76,792

)

(93,505

)

(262,976

)

Payment of contingent consideration related to a business combination

(5,470

)

(5,390

)

Payment of excise taxes on share repurchases

(1,491

)

(1,491

)

Net cash used in financing activities

(25,243

)

(75,500

)

(101,468

)

(262,446

)

Net increase (decrease) in cash and cash equivalents

(18,978

)

14,686

68,485

(34,938

)

Cash and cash equivalents, beginning of period

184,248

108,403

96,785

158,027

Cash and cash equivalents, end of period

$

165,270

$

123,089

$

165,270

$

123,089

Supplemental disclosures of cash flow information

Cash paid for taxes, net of refunds

$

13,829

$

8,925

$

35,814

$

38,363

Non-GAAP Financial Measures

To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:

We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results.

Key Business Metrics

Reconciliation of GAAP to Non-GAAP Financial Measures

The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:

Three Months Ended
December 31,

Nine Months Ended
December 31,

2024

2023

2024

2023

(unaudited)

(in thousands, except percentages)

Net income

$

75,196

$

47,956

$

160,727

$

106,964

Adjusted to exclude the following:

Stock-based compensation

19,368

11,771

54,326

35,573

Depreciation and amortization

2,655

2,509

7,830

7,717

Provision for income taxes

14,644

15,076

44,453

30,285

Restructuring and impairment charges

2,304

7,936

Change in fair value of contingent earn-out consideration liability

90

452

513

768

Other income, net

(9,915

)

(4,481

)

(26,060

)

(15,223

)

Adjusted EBITDA

$

102,038

$

73,283

$

244,093

$

174,020

Revenue

$

168,603

$

135,284

$

432,111

$

357,365

Net income margin

44.6

%

35.4

%

37.2

%

29.9

%

Adjusted EBITDA margin

60.5

%

54.2

%

56.5

%

48.7

%

Three Months Ended
December 31,

Nine Months Ended
December 31,

2024

2023

2024

2023

(unaudited)

(in thousands)

Net cash provided by operating activities

$

65,189

$

50,054

$

174,778

$

120,152

Purchases of property and equipment

(36

)

(147

)

Internal-use software development costs

(1,771

)

(1,288

)

(5,018

)

(4,020

)

Free cash flow

$

63,418

$

48,730

$

169,760

$

115,985

Other cash flow components:

Net cash provided by (used in) investing activities

$

(58,924

)

$

40,132

$

(4,825

)

$

107,356

Net cash used in financing activities

$

(25,243

)

$

(75,500

)

$

(101,468

)

$

(262,446

)

Three Months Ended
December 31,

Nine Months Ended
December 31,

2024

2023

2024

2023

(unaudited)

(in thousands, except per share data and percentages)

GAAP cost of revenue

$

14,181

$

12,190

$

41,407

$

38,102

Adjusted to exclude the following:

Stock-based compensation

(2,818

)

(2,466

)

(8,373

)

(7,205

)

Amortization of acquired intangibles

(274

)

Non-GAAP cost of revenue

$

11,363

$

9,724

$

33,034

$

30,623

GAAP gross profit

$

154,422

$

123,094

$

390,704

$

319,263

Adjusted to exclude the following:

Stock-based compensation

2,818

2,466

8,373

7,205

Amortization of acquired intangibles

274

Non-GAAP gross profit

$

157,240

$

125,560

$

399,077

$

326,742

GAAP gross margin

91.6

%

91.0

%

90.4

%

89.3

%

Non-GAAP gross margin

93.3

%

92.8

%

92.4

%

91.4

%

GAAP research and development expense

$

22,421

$

19,946

$

68,235

$

61,835

Adjusted to exclude the following:

Stock-based compensation

(4,471

)

(3,080

)

(14,602

)

(8,874

)

Non-GAAP research and development expense

$

17,950

$

16,866

$

53,633

$

52,961

GAAP sales and marketing expense

$

38,491

$

34,956

$

108,102

$

99,612

Adjusted to exclude the following:

Stock-based compensation

(6,487

)

(4,060

)

(19,881

)

(12,752

)

Amortization of acquired intangibles

(1,061

)

(1,061

)

(3,183

)

(3,183

)

Change in fair value of contingent earn-out consideration liability

(90

)

(452

)

(513

)

(768

)

Non-GAAP sales and marketing expense

$

30,853

$

29,383

$

84,525

$

82,909

GAAP general and administrative expense

$

13,585

$

9,641

$

32,943

$

27,854

Adjusted to exclude the following:

Stock-based compensation

(5,592

)

(2,165

)

(11,470

)

(6,742

)

Non-GAAP general and administrative expense

$

7,993

$

7,476

$

21,473

$

21,112

GAAP operating expense

$

74,497

$

64,543

$

211,584

$

197,237

Adjusted to exclude the following:

Stock-based compensation

(16,550

)

(9,305

)

(45,953

)

(28,368

)

Amortization of acquired intangibles

(1,061

)

(1,061

)

(3,183

)

(3,183

)

Change in fair value of contingent earn-out consideration liability

(90

)

(452

)

(513

)

(768

)

Restructuring and impairment charges

(2,304

)

(7,936

)

Non-GAAP operating expense

$

56,796

$

53,725

$

159,631

$

156,982

GAAP operating income

$

79,925

$

58,551

$

179,120

$

122,026

Adjusted to exclude the following:

Stock-based compensation

19,368

11,771

54,326

35,573

Amortization of acquired intangibles

1,061

1,061

3,183

3,457

Change in fair value of contingent earn-out consideration liability

90

452

513

768

Restructuring and impairment charges

2,304

7,936

Non-GAAP operating income

$

100,444

$

71,835

$

239,446

$

169,760

GAAP net income

$

75,196

$

47,956

$

160,727

$

106,964

Adjusted to exclude the following:

Stock-based compensation

19,368

11,771

54,326

35,573

Amortization of acquired intangibles

1,061

1,061

3,183

3,457

Change in fair value of contingent earn-out consideration liability

90

452

513

768

Restructuring and impairment charges

2,304

7,936

Income tax effect of non-GAAP adjustments (1)

(4,309

)

(2,790

)

(12,668

)

(10,024

)

Non-GAAP net income

$

91,406

$

58,450

$

208,385

$

144,674

Non-GAAP net income margin

54.2

%

43.2

%

48.2

%

40.5

%

Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:

Basic

187,161

186,309

186,344

191,302

Diluted

202,233

200,463

200,625

207,265

Non-GAAP net income per share attributable to Class A and Class B stockholders:

Basic

$

0.49

$

0.31

$

1.12

$

0.76

Diluted

$

0.45

$

0.29

$

1.04

$

0.70

(1) For the three and nine months ended December 31, 2024 and 2023, management used an estimated annual effective non-GAAP tax rate of 21.0%.

Investor Relations Contact:

Perry Gold

[email protected]

Media Contact:

Amanda Cox

[email protected]

Source: Doximity

Categories

Business Wire Press Releases

Next Articles